Revolution Medicines Inc (RVMD)
Revolution Medicines Inc (RVMD) carries a ŷRobot AI score of 47 out of 100. The model's fair value estimate is $162.98, 5.4% below the last close of $172.29. The chart signal reads Bullish.
| Metric | RVMD |
|---|---|
| AI score | 47 / 100 |
| Chart signal | Bullish |
| Fair value estimate | $162.98 |
| Upside to fair value | -5.4% |
| Previous close | $172.29 |
| P/E | -21.85 |
| Price / sales | 51,316.43 |
| Market cap | $39.08B |
| EPS | -8.13 |
| Revenue growth | -100.3% |
| 1-year price change | 17.1% |
How these numbers are built: the AI score, the fair value model, and the chart signal.
Other Healthcare stocks: Eli Lilly and Company, Johnson & Johnson, AbbVie Inc, Merck & Company Inc, UnitedHealth Group Incorporated, Novartis AG ADR.
Questions about RVMD
Is RVMD overvalued or undervalued right now?
As of Nov 6, 2026, ŷRobot's fair-value model estimates Revolution Medicines Inc (RVMD) at $162.98 against a last close of $172.29, implying 5.4% downside to the model's estimate.
Is RVMD's chart signal bullish or bearish?
The chart-signal model classifies RVMD as Neutral as of Nov 13, 2026, with a signal score of 0.14 on a -1 to 1 scale.
What is RVMD's ŷRobot AI score?
RVMD scores 47 out of 100 on ŷRobot's AI composite, which measures how strongly the fair-value and chart models agree, as of Nov 13, 2026.
Is RVMD stock expensive on P/E and P/S?
RVMD trades at -21.9 times earnings and 51316.4 times sales as of Nov 13, 2026.
What does RVMD's seasonal forecast show?
ŷRobot's seasonal forecast curve for RVMD reads +5.4% at 30 days, +10.6% at 90 days, and +17.1% at one year as of Nov 13, 2026. Seasonal tendencies are historical patterns, not predictions.
How fast is RVMD growing?
Revolution Medicines Inc's revenue growth is -100.3% and free-cash-flow growth is +0.8% on the latest reported figures.
RVMD chart and technical read · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.